New publications in health economics and genomics 30th August 2022

Three publications from the past week:

  • Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation | link
  • Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature | link
  • The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 23rd August 2022

Four publications from the past week:

  • Cost-Effectiveness of Exome Sequencing versus Targeted Gene Panels for Prenatal Diagnosis of Fetal Effusions and Non-Immune Hydrops Fetalis | link
  • Preferences for a polygenic test to estimate cancer risk in a general Australian population | link
  • Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer | link
  • Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 16th August 2022

Four publications from the past week:

  • Economic evaluation of genomic/genetic tests: a review and future directions | link
  • Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis | link
  • Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States | link
  • Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 9th August 2022

One publication from the past week:

  • Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.